Characteristics | Categories or parameters | Numbers (%) | Alive | Died of CRC | Died of other causes |
Total cohort, n (%) | 1861 | 1201 (64.5) | 550 (29.6) | 110 (5.9) | |
Mean age at enrolment | Years (SD) (range) | 55.8 (7.3) (41–75) | 55.0 (6.9) (41–75) | 56.6 (7.5) (41–74) | 61.2 (7.4) (41–75) |
Mean age at diagnosis | Years (SD) (range) | 66.4 (8.7) (43–89) | 66.4 (8.3) (43–89) | 65.5 (9.4) (43–87) | 70.6 (8.6) (50–86) |
Mean age at death | Years (SD) (range) | 69.0 (47–89) | 67.6 (9.1) (47–88) | 75.9 (8.6) (50–89) | |
Mean prediagnostic follow-up duration | Years (SD) | 10.5 (5.4) | 11.3 (5.3) | 8.8 (5.2) | 9.3 (4.7) |
Mean postdiagnosis survival duration | Years (SD) | 5.0 (4.7) | 6.4 (5.0) | 2.1 (2.3) | 5.3 (4.3) |
CRC stage, n (%) | Localised | 452 (24.3) | 377 (31.4) | 32 (5.8) | 43 (39.1) |
Regional spread | 972 (52.2) | 730 (60.8) | 188 (34.2) | 54 (49.1) | |
Remote metastases | 437 (23.5) | 94 (7.8) | 330 (60.0) | 13 (11.8) | |
Physical activity | 1–2 (least active) | 83 (5.2) | 46 (4.4) | 26 (5.4) | 11 (12.4) |
3–4 | 366 (22.7) | 236 (22.7) | 112 (23.3) | 18 (20.2) | |
5–6 | 687 (42.6) | 458 (43.9) | 198 (41.3) | 31 (34.8) | |
7–8 | 385 (23.9) | 248 (23.8) | 116 (24.2) | 21 (23.6) | |
9–10 (most active) | 90 (5.6) | 54 (5.2) | 28 (5.8) | 8 (9.0) | |
Body mass index, n (%) | Underweight (<20.0) | 100 (5.5) | 52 (4.4) | 41 (7.7) | 7 (6.6) |
Normal (20.0–24.9) | 883 (48.7) | 583 (49.6) | 253 (47.6) | 47 (44.4) | |
Overweight (25.0–29.9) | 640 (35.3) | 417 (35.5) | 188 (35.3) | 35 (3.0) | |
Obese ≥30.0 | 190 (10.5) | 123 (10.5) | 50 (9.4) | 17 (16.0) | |
Duration of education | <10 years | 658 (38.2) | 413 (36.9) | 197 (39.2) | 48 (48.0) |
10–12 years | 583 (33.9) | 383 (34.2) | 171 (34.1) | 29 (29.0) | |
>12 years | 480 (27.9) | 323 (28.9) | 134 (26.7) | 23 (23.0) | |
Annual household income | <300 000 NOK | 857 (50.7) | 515 (46.7) | 274 (55.8) | 68 (70.1) |
301 000–600 000 NOK | 688 (40.6) | 483 (43.7) | 178 (36.3) | 27 (27.8) | |
>600 000 NOK | 147 (8.7) | 106 (9.6) | 39 (7.9) | 2 (2.1) | |
Alcohol intake (g/day) | None | 472 (27.5) | 315 (28.3) | 119 (23.5) | 38 (38.4) |
≤3.0 g | 720 (41.9) | 447 (40.2) | 231 (45.5) | 42 (42.4) | |
>3.0–10.0 g | 395 (23.0) | 259 (23.3) | 121 (23.9) | 15 (15.2) | |
>10.0 g | 131 (7.6) | 91 (8.2) | 36 (7.1) | 4 (4.0) | |
Smoking status | Never smoker | 627 (34.2) | 410 (34.7) | 173 (31.9) | 44 (40.7) |
Former smoker | 666 (36.4) | 437 (37.0) | 202 (37.3) | 27 (25.0) | |
Current smoker | 538 (29.4) | 334 (28.3) | 167 (30.8) | 37 (34.3) | |
Red and processed meat intake combined (g/day) | ≤70.0 g | 1523 (81.8) | 986 (82.1) | 444 (80.7) | 93 (84.6) |
>70.0 g | 338 (18.2) | 215 (17.9) | 106 (19.3) | 17 (15.4) | |
Fish intake (g/day) | ≤130 g | 1364 (73.3) | 890 (74.1) | 401 (72.9) | 73 (66.4) |
>130 g | 497 (26.7) | 311 (25.9) | 149 (27.1) | 37 (33.6) | |
Fruit and vegetable intake (g/day) | ≤300 g | 1002 (53.8) | 629 (52.4) | 296 (53.8) | 77 (70.0) |
>300 g | 859 (46.2) | 572 (47.6) | 254 (46.2) | 33 (30.0) | |
Vitamin D intake (μg/day) | ≤10.0 µg | 1340 (72.0) | 851 (70.9) | 411 (74.7) | 78 (70.9) |
>10.0 µg | 521 (28.0) | 350 (29.1) | 139 (25.3) | 32 (29.1) | |
Diabetes mellitus, n (%) | No | 1813 (97.4) | 1175 (97.8) | 532 (96.7) | 106 (96.4) |
Yes | 48 (2.6) | 26 (2.2) | 18 (3.3) | 4 (3.6) | |
Cardiovascular diseases | No | 1503 (80.8) | 981 (81.7) | 450 (81.8) | 72 (65.4) |
Yes | 358 (19.2) | 220 (18.3) | 100 (18.2) | 38 (34.6) |
CRC, colorectal cancer; NOK, Norwegian kroner; SD, standard deviation.